Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • BD Technologies
    Registered Vendor
    • Nov 2011
    • 1

    #1

    Senior Manager - Next Generation Sequencing

    Did you know our company is seeking you?

    Senior Manager – Next Generation Sequencing (NGS)
    BD Technologies, Research Triangle Park, NC
    Requisition # LIF10063

    About Us:
    BD is a leading global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. For more information, please visit http://www.bd.com.

    BD is an Equal Opportunity/Affirmative Action Employer

    Senior Manager, Next Generation Sequencing (NGS) will be responsible for establishing, with leadership in BD businesses and BDT, the strategy for NGS and for developing and executing the technical milestones, work plans and budget in support of the strategy.

    Duties and Responsibilities:

    The incumbent will manage the activities of technical staff in the areas of sample preparation, sequencing, library development and bioinformatics and will be responsible for implementation, execution and sponsorship of technology development between BDT and BD businesses.

    The incumbent will also manage the technical activities of cross-business internal technical teams (BDT and BD DS) and external parties including commercial partners, university collaborators and Genomics institutes, as appropriate.

    He or she will directly engage both internal and external stakeholders in the NGS field and will play an important role in achieving BDX Delta growth objectives.
    • Execute NGS technology development program and manage a multi-disciplinary group of scientists, bioinformaticians and statisticians participating in the program.
    • Participate in the development of the NGS strategy.
    • Prepare and manage technical milestones, work plans and budget.


    Qualifications:
    Requirements and Relevant Experience:
    • PhD in relevant biological or chemical science field with experience in bioinformatics.
    • Minimum of 10 years experience in molecular biology with a minimum of 5 years of hands-on technical experience in gene sequencing.
    • Hands-on experience with next generation sequencing technologies.
    • Demonstrated ability to manage projects and lead interdisciplinary teams.
    • Excellent interpersonal as well as verbal and written skills are required.


    To apply for a position, please log on to http://www.bd.com/careers, click on ‘Search Jobs,’ and follow the guidelines to locate your position of interest.
    Reference: Requisition # LIF10063

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...